drugdeliverybusiness3h
Data outlines need for CGM study design guidelines
A study highlighted the accuracy of three leading continuous glucose monitors (CGM), including systems from Abbott and Dexcom.
FiercePharma4h
Abbott's stigma-busting campaign shows how diabetes biases lead to silence, skipped care
A new awareness campaign from Abbott highlights a major sticking point in diabetes management: the harmful impact of societal ...
Zacks.com on MSN9h
PODD Stock Falls Despite Q4 Earnings and Revenue Beat, Margins Rise
Insulet Corporation PODD reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.15, down significantly 17.8% ...
Expanding Diabetes Business Supports ABT Stock, FX Issues Stay
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...
drugdeliverybusiness3d
Medtronic seeks to expand MiniMed 780G label to type 2 diabetes, submits new CGM to FDA
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
Diabetes: How Can You Check Blood Sugar Without Pricking Your Fingertips?
There are various blood sugar monitors for those with diabetes and it is important to have regular monitoring done. While ...
securities6d
A Breakthrough in Medical Monitoring: Next-Gen Medical Stabilization with Nanoparticle-Based Wearable Biosensors
Against the backdrop of aging, chronic diseases, and a growing population, the healthcare system is going through a vital transformation. Healthcare is simply becoming increasingly individual-centric.